A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart
Open Access
- 1 December 2005
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (7) , 952-957
- https://doi.org/10.1038/sj.bjp.0706402
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Beneficial Effects of Bradykinin on Myocardial Energy Metabolism and Infarct SizeThe American Journal of Cardiology, 1997
- Bradykinin Protects Against Infarction but Does not Mediate Ischemic Preconditioning in the Isolated Rat HeartJournal of Molecular and Cellular Cardiology, 1996
- Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit HeartsCirculation Research, 1995
- Strategy of Measuring Bradykinin and Kallidin and Their Concentration in Plasma and UrineAnalytical Biochemistry, 1995
- Protective Role of Bradykinin in Cardiac AnaphylaxisCirculation Research, 1995
- Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptorsBritish Journal of Pharmacology, 1994
- Role of bradykinin in myocardial preconditioning.1994
- A local kallikrein-kinin system is present in rat hearts.Hypertension, 1994
- Sympathetically induced myocardial ischaemia causes the heart to release plasma kininCardiovascular Research, 1987
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986